Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Michael S Hofman

[ 177 Lu]-Psma-617 Radionuclide Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer – Author's Reply

The Lancet Oncology
Oncology
2018English

Utility of 68 Ga Prostate Specific Membrane Antigen - Positron Emission Tomography in Diagnosis and Response Assessment of Recurrent Renal Cell Carcinoma

Journal of Medical Imaging and Radiation Oncology
OncologyRadiologyNuclear MedicineImaging
2017English

Related publications

Predictors of Response to Radioligand Therapy of Metastatic Castrate-Resistant Prostate Cancer With 177 Lu-Psma-617

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2016English

225Ac-Psma-617 for PSMA-Targeted -Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2016English

Dosimetry of Lu-177 PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: Correlations Between Pre-Therapeutic Imaging and “Whole Body” Tumor Dosimetry With Treatment Outcomes

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2018English

Targeted Α-Therapy of Metastatic Castration-Resistant Prostate Cancer With225Ac-Psma-617: Dosimetry Estimate and Empiric Dose Finding

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2017English

Predictive Factors of Response and Overall Survival in Patients With Castration-Resistant Metastatic Prostate Cancer Undergoing177Lu-Psma Therapy

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2018English

Prolonged Therapy With Cabazitaxel in an Octogenarian With Metastatic Castration-Resistant Prostate Cancer

Clinical Genitourinary Cancer
OncologyUrology
2012English

Pilot Study of Hyperfractionated Dosing of Lutetium‐177–Labeled Antiprostate‐Specific Membrane Antigen Monoclonal Antibody J591 ( 177 Lu‐J591) for Metastatic Castration‐Resistant Prostate Cancer

Oncologist
Cancer ResearchMedicineOncology
2020English

Prostate-Specific Membrane Antigen–Directed Therapy for Metastatic Castration-Resistant Prostate Cancer

Cancer Journal
Cancer ResearchOncology
2016English

Clinical Outcome of Standardized 177Lu-Psma-617 Therapy in Metastatic Prostate Cancer Patients Receiving 7400 MBq Every 4 Weeks

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy